Skip to main content
Apontis Pharma AG (ETR:APPH)
Germany flag Germany · Delayed Price · Currency is EUR
11.45
+0.30 (2.69%)
Apr 24, 2025, 5:36 PM CET

Apontis Pharma AG Revenue

In the year 2024, Apontis Pharma AG had annual revenue of 48.47M EUR with 31.12% growth. Apontis Pharma AG had revenue of 25.74M in the half year ending December 31, 2024, a decrease of -4.90%.

Revenue
48.47M
Revenue Growth
+31.12%
P/S Ratio
1.92
Revenue / Employee
353.78K
Employees
137
Market Cap
92.88M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202448.47M11.50M31.12%
Dec 31, 202336.96M-18.76M-33.67%
Dec 31, 202255.73M4.54M8.87%
Dec 31, 202151.18M11.94M30.44%
Dec 31, 202039.24M-794.91K-1.99%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.16B
Siemens Healthineers AG 22.67B
Fresenius SE & Co. KGaA 21.83B
Bayer Aktiengesellschaft 46.61B
Sartorius Aktiengesellschaft 3.44B
Fresenius Medical Care AG 19.34B
Carl Zeiss Meditec AG 2.08B
Fielmann Group AG 2.16B
Revenue Rankings

Apontis Pharma AG News

More News